Ameloblastin (Enamel Matrix Protein) (AMBN) (C-Term) Peptide
-
- Target See all AMBN products
- AMBN (Ameloblastin (Enamel Matrix Protein) (AMBN))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- RPGFEGMPHN PAMGGDFTLE FDSPVAATKG PENEEGGAQG SPMPEANPDN
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-AMBN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AMBN (Ameloblastin (Enamel Matrix Protein) (AMBN))
- Synonyms
- ameloblastin Peptide, Ambn Peptide, AMBN Peptide
- Background
-
Ameloblastin is thought to represent an unique ameloblast-specific gene product that may be important in enamel matrix formation and mineralization. The gene is located on chromosome 4 near other genes associated with mineralized tissues: osteopontin, bone sialoprotein, and bone morphogenetic protein 3. Based on its cytogenetic location, this gene is a candidate gene for one form of the disorder, dentinogenesis imperfecta, and/or the disorder, autosomal dominant amylogenesis imperfecta.
Alias Symbols: -
Protein Size: 447 - Molecular Weight
- 49 kDa
- Gene ID
- 258
- NCBI Accession
- NM_016519, NP_057603
- UniProt
- Q9NP70
-